The FDA has granted Forest Laboratories and Pierre Fabre Labs approval for their once-daily Fetzima drug to treat patients with major depressive disorder. The drug is a serotonin and norepinephrine reuptake inhibitor.
Forest Labs, Pierre Fabre Labs gain FDA approval for Fetzima
SmartBrief Job Listings for Health Care
|President/Chief Executive Officer||
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Director, Payer Marketing||
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Chief Medical Officer, Texas Children's Health Plan||
Cejka Executive Search for Texas Childre's Health Plan